Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
Authors
Keywords
-
Journal
Science Signaling
Volume 11, Issue 557, Pages eaap9752
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-11-21
DOI
10.1126/scisignal.aap9752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Performance Evaluation of the Q Exactive HF-X for Shotgun Proteomics
- (2017) Christian D. Kelstrup et al. JOURNAL OF PROTEOME RESEARCH
- Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance
- (2017) Kristina B. Emdal et al. MOLECULAR CANCER THERAPEUTICS
- FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3
- (2017) M Rupp et al. ONCOGENE
- Rho-associated kinase is a therapeutic target in neuroblastoma
- (2017) Cecilia Dyberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas
- (2017) Ganesh Umapathy et al. Science Signaling
- Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
- (2017) Hui Qin Wang et al. eLife
- MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas
- (2017) Ganesh Umapathy et al. Science Signaling
- An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes
- (2017) Dorte B. Bekker-Jensen et al. Cell Systems
- The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
- (2016) J. Guan et al. Disease Models & Mechanisms
- Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking
- (2016) Chiara Francavilla et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Non-metabolic functions of glycolytic enzymes in tumorigenesis
- (2016) X Yu et al. ONCOGENE
- Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors
- (2016) G. Zhang et al. Science Signaling
- Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking
- (2016) Chiara Francavilla et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors
- (2016) G. Zhang et al. Science Signaling
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
- (2015) Frederick H. Wilson et al. CANCER CELL
- Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
- (2015) I. Lambertz et al. CLINICAL CANCER RESEARCH
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer
- (2015) Gorjan Hrustanovic et al. NATURE MEDICINE
- Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions
- (2015) Andrey V. Reshetnyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
- (2015) K. B. Emdal et al. Science Signaling
- The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma
- (2015) N. R. Infarinato et al. Cancer Discovery
- FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
- (2015) Jikui Guan et al. eLife
- Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation
- (2015) K. B. Emdal et al. Science Signaling
- Insulin Receptor Substrate 2-mediated Phosphatidylinositol 3-kinase Signaling Selectively Inhibits Glycogen Synthase Kinase 3β to Regulate Aerobic Glycolysis
- (2014) Justine Landis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid and Deep Proteomes by Faster Sequencing on a Benchtop Quadrupole Ultra-High-Field Orbitrap Mass Spectrometer
- (2014) Christian D. Kelstrup et al. JOURNAL OF PROTEOME RESEARCH
- Off-Line High-pH Reversed-Phase Fractionation for In-Depth Phosphoproteomics
- (2014) Tanveer S. Batth et al. JOURNAL OF PROTEOME RESEARCH
- Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
- (2014) Jürgen Cox et al. MOLECULAR & CELLULAR PROTEOMICS
- Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer
- (2014) Christine M Lovly et al. NATURE MEDICINE
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
- (2014) G. Umapathy et al. Science Signaling
- FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma
- (2013) E. E. Santo et al. CANCER RESEARCH
- Comparison of SILAC and mTRAQ Quantification for Phosphoproteomics on a Quadrupole Orbitrap Mass Spectrometer
- (2013) Felix S. Oppermann et al. JOURNAL OF PROTEOME RESEARCH
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
- (2013) Pushpendra Singh et al. MEDICAL ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- A Map of General and Specialized Chromatin Readers in Mouse Tissues Generated by Label-free Interaction Proteomics
- (2012) H. Christian Eberl et al. MOLECULAR CELL
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma
- (2012) E L Carpenter et al. ONCOGENE
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The insulin receptor substrate (IRS) proteins
- (2011) Leslie M. Shaw CELL CYCLE
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
- (2011) Jürgen Cox et al. JOURNAL OF PROTEOME RESEARCH
- Global quantification of mammalian gene expression control
- (2011) Björn Schwanhäusser et al. NATURE
- Mapping Insulin/GLUT4 Circuitry
- (2011) Alexander F. Rowland et al. TRAFFIC
- p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
- (2010) L. Chen et al. CANCER RESEARCH
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis
- (2009) Bhumsoo Kim et al. APOPTOSIS
- SH2B1 Enhances Insulin Sensitivity by Both Stimulating the Insulin Receptor and Inhibiting Tyrosine Dephosphorylation of Insulin Receptor Substrate Proteins
- (2009) D. L. Morris et al. DIABETES
- Improved visualization of protein consensus sequences by iceLogo
- (2009) Niklaas Colaert et al. NATURE METHODS
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours
- (2008) Helena Carén et al. BIOCHEMICAL JOURNAL
- The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
- (2008) Stefan Hanke et al. MOLECULAR & CELLULAR PROTEOMICS
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started